ftInvstr
SYNGENE · Healthcare ₹395.15 -1.3% Mkt Cap ₹15922 Cr fair

SYNGENE

Healthcare Diagnostics & Research
₹395.15
-1.3% today · 30d -1.21%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SYNGENE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹736 Cr
-15.84% YoY
NET PROFIT
₹-9 Cr
-110.38% YoY
OPM
15.25%
-9.87pp YoY
EPS
₹-0.22
PE 70.78
Intrinsic value · DCF ₹450.16 · Margin of safety +13.9% (fair) · FCF yield 3.59%
◇ Sector Position
PEERPEROCE %
SYNGENE70.7810.0
SAILIFE93.1518.42
LALPATHLAB62.2931.74
VIJAYA81.3726.15
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
41
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 20
Growth MUTED 36
Profitability DECENT 68
Technicals WEAK 37
Risk LOW 80
Key Stats
TTM PE
70.78
P/B
3.23
52W HIGH
₹684.6
OFF HIGH
-42.28%
DIV YIELD
0.32%
MKT CAP
₹15922 Cr
◉ Active Signals
MACDBearish-0.0257
RSI(14)Neutral42.02
Near 52W LowBearish5.3
Street Consensus
8 analysts
₹501.88
mean target
Low ₹340.0Now ₹395.15High ₹735.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SYNGENE and at what entry.

Sign up freeSign in